Marshall Wace, LLP Biolife Solutions Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$15.14 - $22.99 $161,922 - $245,878	10,695 New	10,695 $229,000
Q2 2022 Aug 15, 2022	SELL	$10.54 - $24.2 $9.33 Million - $21.4 Million	-885,459 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$20.81 - $37.29 $9.6 Million - $17.2 Million	-461,287 Reduced 34.25%	885,459 $20.1 Million
Q4 2021 Feb 14, 2022	BUY	$32.99 - $58.55 $1.8 Million - $3.19 Million	54,502 Added 4.22%	1,346,746 $50.2 Million
Q3 2021 Nov 15, 2021	SELL	$42.03 - $60.5 $19.9 Million - $28.7 Million	-474,448 Reduced 26.86%	1,292,244 $54.7 Million
Q2 2021 Aug 13, 2021	BUY	$29.51 - $44.62 $17.4 Million - $26.4 Million	590,659 Added 50.22%	1,766,692 $78.6 Million
Q1 2021 May 17, 2021	BUY	$32.95 - $44.24 $473,425 - $635,640	14,368 Added 1.24%	1,176,033 $42.3 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $45.75 $31.9 Million - $53.1 Million	1,161,665 New	1,161,665 $46.3 Million
Q3 2020 Nov 16, 2020	SELL	$16.04 - $28.94 $160,945 - $290,383	-10,034 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$9.2 - $17.06 $678,978 - $1.26 Million	-73,802 Reduced 88.03%	10,034 $164,000
Q1 2020 May 15, 2020	BUY	$8.36 - $17.03 $312,179 - $635,934	37,342 Added 80.32%	83,836 $796,000
Q4 2019 Feb 14, 2020	BUY	$14.59 - $18.9 $678,347 - $878,736	46,494 New	46,494 $752,000
Q3 2019 Nov 14, 2019	SELL	$15.7 - $20.98 $662,540 - $885,356	-42,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$15.2 - $19.42 $181,214 - $231,525	11,922 Added 39.38%	42,200 $715,000
Q1 2019 May 14, 2019	BUY	$10.9 - $21.26 $223,580 - $436,085	20,512 Added 210.03%	30,278 $542,000
Q4 2018 Feb 14, 2019	BUY	$9.5 - $17.17 $92,777 - $167,682	9,766 New	9,766 $117,000

Others Institutions Holding BLFS

# of Institutions

199

Shares Held

45M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account